MSB 0.36% $1.39 mesoblast limited

Cell Therapy News/Articles, page-2482

  1. 3,828 Posts.
    lightbulb Created with Sketch. 461
    bloody hell and I thought all the trials were started by the 1,250 other pharm cpys & we are all impatiently awaiting results over next few weeks form them all (its going to be bedlam) and now another tonight on the news in Queensland. Tocilizumab. Study/trial by a research institute QIMR Berghofer Medical Research Institute (?) so I checked about and the drug is owned by ROCHE...
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.